Fangming Wang

10PUBLICATIONS
12CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Development and Validation of a Novel Indicator for Differential Diagnosis of Clinically Significant Prostate Cancer Based on Comprehensive Hematological Testing.

|Feb 23, 2026
Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

Fangming Wang, Dong Wang, Jianxing Li

|Jan 15, 2026
Reliability of Negative Prostate MRI for Biopsy Decision-Making in the Male Han Chinese Population.

Fangming Wang, Yan Zhang, Meng Fu

|Jun 13, 2022
Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.

Fangming Wang, Liyuan Wu, Le Yin

|Apr 22, 2022
Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer.

Fangming Wang, Xuejiao Dong, Jing Wang

|Feb 03, 2021
Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Underwent Transrectal Ultrasound-Guided Prostate Biopsy.

Fang-Ming Wang, Nian-Zeng Xing

Pageof 2

Frequent Collaborators

3 joint publications

Lijiang Sun

3 joint publications

Nianzeng Xing

2 joint publications

Guiming Zhang

2 joint publications

Jianxing Li